New light-activated technology enhances immune cells' ability to target solid tumors

[Ketua Dobbs]

New light-activated technology enhances immune cells' ability to target solid tumors

Immunotherapies that mobilize a patient's own immune system to fight cancer have become a treatment pillar. These therapies, including CAR T-cell therapy, have performed well in cancers like leukemias and lymphomas, but the results have been less promising in solid tumors.
Source: New light-activated technology enhances immune cells' ability to target solid tumors